Pentwater Capital Management LP Q4 2020 Filing

Filed February 16, 2021

Portfolio Value

$8.3B

Holdings

235

Report Date

Q4 2020

Filing Type

13F-HR

All Holdings (235 positions)

StockValue
TREAN INS GROUP INC
$453K
CHWYCHEWY INC
$449K
CHIASMA INC
$435K
ARRYARRAY TECHNOLOGIES INC
$431K
PREVAIL THERAPEUTICS INC
$408K
UBERUBER TECHNOLOGIES INC
$408K
BNTXBIONTECH SE
$408K
GMABGENMAB A/S
$407K
DATTO HLDG CORP
$405K
NTSTNETSTREIT CORP
$390K
MRNAMODERNA INC
$366K
LESLIES INC
$347K
ORICORIC PHARMACEUTICALS INC
$339K
ADCTADC THERAPEUTICS SA
$320K
AMERICAN AIRLS GROUP INC
$315K
GAN LTD
$304K
PTONPELOTON INTERACTIVE INC
$303K
ALGMALLEGRO MICROSYSTEMS INC
$280K
LYRALYRA THERAPEUTICS INC
$271K
ALLOALLOGENE THERAPEUTICS INC
$252K
AJRDEURAEROJET ROCKETDYNE HLDGS INC
$238K
LUVSOUTHWEST AIRLS CO
$233K
DRAGONEER GROWTH OPPORTUN CO
$228K
SILKSILK RD MED INC
$220K
VASTA PLATFORM LTD
$218K
BCYCBICYCLE THERAPEUTICS PLC
$215K
OZONOZON HLDGS PLC
$207K
VIA OPTRONICS AG
$201K
RAPTRAPT THERAPEUTICS INC
$198K
PROGENITY INC
$197K
TRANSLATE BIO INC
$184K
CENTOGENE N V
$181K
MCAFEE CORP
$167K
AALAMERICAN AIRLS GROUP INC
$146K
ALTIMETER GROWTH CORP
$130K
PreviousPage 3 of 3